{
    "thread": {
        "uuid": "a59e8ca15369b29f26936de6406dea986f74dea8",
        "url": "https://techdows.com/2025/01/09/hemostemix-cvehem-stock-price-up-20-7-whats-next/673478.html",
        "site_full": "techdows.com",
        "site": "techdows.com",
        "site_section": "https://www.techdows.com",
        "site_categories": [
            "tech"
        ],
        "section_title": "Techdows News",
        "title": "Hemostemix (CVE:HEM) Stock Price Up 20.7% - What's Next?",
        "title_full": "Hemostemix (CVE:HEM) Stock Price Up 20.7% - What's Next?",
        "published": "2025-01-10T01:44:00.000+02:00",
        "replies_count": 0,
        "participants_count": 1,
        "site_type": "news",
        "country": "US",
        "main_image": "",
        "performance_score": 0,
        "domain_rank": 84128,
        "domain_rank_updated": "2025-01-06T23:00:00.000+02:00",
        "social": {
            "facebook": {
                "likes": 0,
                "comments": 0,
                "shares": 0
            },
            "vk": {
                "shares": 0
            }
        }
    },
    "uuid": "a59e8ca15369b29f26936de6406dea986f74dea8",
    "url": "https://techdows.com/2025/01/09/hemostemix-cvehem-stock-price-up-20-7-whats-next/673478.html",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "Tech Dows",
    "published": "2025-01-10T01:44:00.000+02:00",
    "title": "Hemostemix (CVE:HEM) Stock Price Up 20.7% - What's Next?",
    "text": "Hemostemix Inc. ( CVE:HEM – Get Free Report )’s stock price traded up 20.7% on Thursday . The stock traded as high as C$0.24 and last traded at C$0.18. 691,700 shares traded hands during mid-day trading, an increase of 54% from the average session volume of 450,083 shares. The stock had previously closed at C$0.15.\nHemostemix Stock Up 31.0 % The stock has a market capitalization of C$16.55 million, a price-to-earnings ratio of -9.50 and a beta of 0.20. The business’s 50-day moving average is C$0.09 and its two-hundred day moving average is C$0.07.\nHemostemix Company Profile ( Get Free Report )\nHemostemix Inc, a clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada. Its lead product is ACP-01, an autologous cell therapy, which is in Phase II clinical trial for the treatment of vascular diseases, such as cardiovascular disease, peripheral arterial disease, angina pectoris, and ischemia.\nRecommended Stories",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "positive",
    "categories": [
        "Economy, Business and Finance",
        "Economy, Business and Finance",
        "Economy, Business and Finance"
    ],
    "topics": [
        "Economy, Business and Finance->financial and economic news",
        "Economy, Business and Finance->business reporting and performance",
        "Economy, Business and Finance->investment and opinion pieces",
        "Economy, Business and Finance->financial service",
        "Economy, Business and Finance->financial and economic news",
        "Economy, Business and Finance->business reporting and performance"
    ],
    "ai_allow": true,
    "has_canonical": false,
    "breaking": null,
    "webz_reporter": false,
    "external_links": [
        "https://www.marketbeat.com/stocks/CVE/HEM/",
        "https://www.marketbeat.com/arnreports/ReportTickerOptin.aspx?RegistrationCode=TickerHyperlink&Prefix=CVE&Symbol=HEM",
        "https://www.marketbeat.com/arnreports/ReportTickerOptin.aspx",
        "https://www.marketbeat.com/stocks/CVE/HEM",
        "https://marketbeat.com/arnreports/ReportTickerOptin.aspx?RegistrationCode=TickerHyperlink&Prefix=CVE&Symbol=HEM",
        "https://marketbeat.com/stocks/CVE/HEM/"
    ],
    "external_images": [],
    "entities": {
        "persons": [],
        "organizations": [
            {
                "name": "Hemostemix Inc.",
                "sentiment": "negative"
            }
        ],
        "locations": []
    },
    "syndication": {
        "syndicated": false,
        "syndicate_id": null,
        "first_syndicated": false
    },
    "rating": null,
    "crawled": "2025-01-10T03:43:30.701+02:00",
    "updated": "2025-01-10T03:43:30.701+02:00"
}